Recce Pharmaceuticals Ltd RCE View profile
Recce Pharmaceuticals advances R327 as diabetes and antibiotic resistance burdens converge
Wednesday 30 September
Today’s Edition
RBA lifts cash rate to 15-year high as inflation risks intensify
The Reserve Bank of Australia has lifted the cash rate by 25 basis points to 4.60%, taking borrowing costs to a 15-year high as persistent inflation and rising energy costs keep pressure on policymakers.
